Errate: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis

Mengyin Ao; Ting Ding; Dan Tang; Mingrong Xi

doi:10.12659/MSM.937457

08 June 2022: Erratum

Errate: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis

Mengyin Ao¹², Ting Ding¹², Dan Tang¹², Mingrong Xi^12*

DOI: 10.12659/MSM.937457

Med Sci Monit 2022; 28:e937457

Authors information Article notes Copyright and License information

0 Comments

Add Comment

Abstract

ABSTRACT: Source of support: This study was supported by grants from the Key Research and Development projects of Sichuan Province (No.2020YFS0129) and the Natural Science Foundation of China (No.61875249). Reference: Mengyin Ao, Ting Ding, Dan Tang, Mingrong Xi: Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis. Med Sci Monit, 2020; 26: e925595. DOI: 10.12659/MSM.925595

Keywords: Endometrial Neoplasms, Endometrium, Female, Humans, Neoplasm Staging, Network Meta-Analysis, Radiotherapy, Adjuvant

Reference

. Ao Mengyin, Ding Ting, Tang Dan, Xi Mingrong, Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I–III: A Systematic Review and Network Meta-Analysis: Med Sci Monit, 2020; 26; e925595, doi: 10.12659/MSM.925595

Link to the original article: https://medscimonit.com/abstract/index/idArt/925595

Related articles Order reprints Share article Share by email

In Press

Review article
Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention

Med Sci Monit In Press; DOI: 10.12659/MSM.947173

0:00

Clinical Research
Serum Prolidase and Ischemia-Modified Albumin Levels in Neural Tube Defects: A Comparative Study of Myelome...

Med Sci Monit In Press; DOI: 10.12659/MSM.947873